Novavax Inc (NASDAQ:NVAX)
| 7.30 BATS BZX Real-Time Price As of 2:26pm ET |  +0.13 / +1.81%Today’s Change | 5.61 Today|||52-Week Range 25.66 | -28.99% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 128.1M | 174.7M | 134.5M | 81.0M | |
| Short Term Investment Cash | 97.0M | 47.9M | -36.0M | -53.5M | ||
| Cash & Short Term Investments | 265.6M | 265.8M | 185.5M | 103.0M | ||
| Receivables | Receivables | 2.3M | 233.0K | 0.00 | 0.00 | |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 19.3M | 21.8M | 17.8M | 16.3M | |
| Current Assets | 287.3M | 287.8M | 203.3M | 119.3M | ||
| Total Assets | Property, Plant and Equipment - Gross | 48.2M | 62.5M | 65.3M | 64.1M | |
| Depreciation | -15.8M | -22.3M | -29.3M | -35.7M | ||
| Intangible Assets | 63.9M | 60.9M | 61.4M | 58.5M | ||
| Other Assets | 64.9M | 61.7M | 62.3M | 59.3M | ||
| Total Assets | 386.0M | 394.3M | 302.5M | 208.0M | ||
| Liabilities | Accounts Payable | 11.9M | 5.7M | 5.6M | 9.3M | |
| Short Term Debt | 395.0K | 0.00 | 0.00 | 0.00 | ||
| Accrued Expenses | 16.9M | 17.2M | 18.4M | 9.9M | ||
| Other Current Liabilities | 53.0M | 53.4M | 56.9M | 26.6M | ||
| Other Liabilities | 76.5M | 66.4M | 73.7M | 45.5M | ||
| Total Liabilities | Long Term Debt | 0.00 | 316.3M | 317.8M | 319.2M | |
| Other Liabilities | 12.7M | 14.6M | 10.3M | 8.7M | ||
| Total Liabilities | 93.4M | 399.8M | 404.2M | 375.9M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 292.7M | -5.5M | -101.7M | -167.9M | ||
| Total Shareholder Equity | 292.7M | -5.5M | -101.7M | -167.9M | ||
| Share Information | Common Shares Outstanding | 13.5M | 13.6M | 16.2M | 19.2M | |
| Addtl. Info. | No data currently available for this section. | |||||
